Choline transport in Leishmania major promastigotes and its inhibition by choline and phosphocholine analogs

Molecular and Biochemical Parasitology

Volumn 125, Issue 1-2, 2002, Pages 127-134

  Zufferey, Rachel ^a   Mamoun, Choukri Ben ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Chemotherapy; Choline analogs; Choline transport; Leishmania; Phosphatidylcholine

Indexed keywords

AMINOQUINOLINE DERIVATIVE; ANTILEISHMANIAL AGENT; CHOLINE; EDELFOSINE; HEMICHOLINIUM 3; MEPACRINE; MILTEFOSINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PHOSPHORYLCHOLINE; QUINIDINE; QUININE;

AMINE TRANSPORT; ANTIMALARIAL ACTIVITY; ARTICLE; BIOSYNTHESIS; CHEMOTHERAPY; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; LEISHMANIA MAJOR; MICHAELIS CONSTANT; NONHUMAN; PARASITE; PARASITE DEVELOPMENT; PRIORITY JOURNAL; PROMASTIGOTE;

CINCHONA PUBESCENS; LEISHMANIA MAJOR;

EID: 0036861867     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(02)00220-7     Document Type: Article

References (57)

1. Ashford R.W. The leishmaniases as emerging and reemerging zoonoses. Int J Parasitol. 30:(12-13):2000;1269-1281.
2. Wassef M.K., Fioretti T.B., Dwyer D.M. Lipid analyses of isolated surface membranes of Leishmania donovani promastigotes. Lipids. 20:(2):1985;108-115.
3. Kent C. Eukaryotic phospholipid biosynthesis. Annu Rev Biochem. 64:1995;315-343.
4. Kent C., Carman G.M. Interactions among pathways for phosphatidylcholine metabolism, CTP synthesis and secretion through the Golgi apparatus. Trends Biochem Sci. 24:(4):1999;146-150.
5. Howe A.G., McMaster C.R. Regulation of vesicle trafficking, transcription, and meiosis: lessons learned from yeast regarding the disparate biologies of phosphatidylcholine. Biochim Biophys Acta. 1534:(2-3):2001;65-77.
6. Voelker D.R. Interorganelle transport of aminoglycerophospholipids. Biochim Biophys Acta. 1486:(1):2000;97-107.
7. Yeo H.J., Larvor M.P., Ancelin M.L., Vial H.J. Plasmodium falciparum CTP:phosphocholine cytidylyltransferase expressed in Escherichia coli: purification, characterization and lipid regulation. Biochem J. 324:(Pt 3):1997;903-910.
8. Yeo H.J., Sri Widada J., Mercereau-Puijalon O., Vial H.J. Molecular cloning of CTP:phosphocholine cytidylyltransferase from Plasmodium falciparum. Eur J Biochem. 233:(1):1995;62-72.
9. Elabbadi N., Ancelin M.L., Vial H.J. Phospholipid metabolism of serine in Plasmodium-infected erythrocytes involves phosphatidylserine and direct serine decarboxylation. Biochem J. 324:(Pt 2):1997;435-445.
10. Vial H.J., Thuet M.J., Philippot J.R. Phospholipid biosynthesis in synchronous Plasmodium falciparum cultures. J Protozool. 29:(2):1982;258-263.
11. Chaudhuri G., Chatterjee T.K., Banerjee A.B. Growth factor requirements for in vitro growth of Leishmania donovani. Indian J Med Res. 76:1982;157-163.
12. Kapler G.M., Coburn C.M., Beverley S.M. Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression. Mol Cell Biol. 10:(3):1990;1084-1094.
13. Das I., de Belleroche J., Moore C.J., Rose F.C. Determination of free choline in plasma and erythrocyte samples and choline derived from membrane phosphatidylcholine by a chemiluminescence method. Anal Biochem. 152:(1):1986;178-182.
14. Felibertt P., Bermudez R., Cervino V., Dawidowicz K., Dagger F., Proverbio T., Marin R., Benaim G. Ouabain-sensitive Na+,K(+)-ATPase in the plasma membrane of Leishmania mexicana. Mol Biochem Parasitol. 74:(2):1995;179-187.
15. Glaser T.A., Utz G.L., Mukkada A.J. The plasma membrane electrical gradient (membrane potential) in Leishmania donovani promastigotes and amastigotes. Mol Biochem Parasitol. 51:(1):1992;9-15.
16. Basselin M., Coombs G.H., Barrett M.P. Putrescine and spermidine transport in Leishmania. Mol Biochem Parasitol. 109:(1):2000;37-46.
17. Mazareb S., Fu Z.Y., Zilberstein D. Developmental regulation of proline transport in Leishmania donovani. Exp Parasitol. 91:(4):1999;341-348.
18. Glaser T.A., Mukkada A.J. Proline transport in Leishmania donovani amastigotes: dependence on pH gradients and membrane potential. Mol Biochem Parasitol. 51:(1):1992;1-8.
19. Burchmore R.J., Hart D.T. Glucose transport in amastigotes and promastigotes of Leishmania mexicana mexicana. Mol Biochem Parasitol. 74:(1):1995;77-86.
20. Zilberstein D., Gepstein A. Regulation of L-proline transport in Leishmania donovani by extracellular pH. Mol Biochem Parasitol. 61:(2):1993;197-205.
21. Wrigglesworth V.B. Digestion in the tsetse fly. Parasitology. 21:1929;288-321.
22. Okuda T., Haga T. Functional characterization of the human high-affinity choline transporter. FEBS Lett. 484:(2):2000;92-97.
23. Okuda T., Haga T., Kanai Y., Endou H., Ishihara T., Katsura I. Identification and characterization of the high-affinity choline transporter. Nat Neurosci. 3:(2):2000;120-125.
24. Apparsundaram S., Ferguson S.M., Blakely R.D. Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter. Biochem Soc Trans. 29:(Pt 6):2001;711-716.
25. Apparsundaram S., Ferguson S.M., George Jr A.L., Blakely R.D. Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochem Biophys Res Commun. 276:(3):2000;862-867.
26. Johnson D.A., Ayres S. Quinacrine noncompetitive inhibitor binding site localized on the Torpedo acetylcholine receptor in the open state. Biochemistry. 35:(20):1996;6330-6336.
27. Martin K. Effects of quaternary ammonium compounds on choline transport in red cells. Br J Pharmacol. 36:(3):1969;458-469.
28. Kirk K., Wong H.Y., Elford B.C., Newbold C.I., Ellory J.C. Enhanced choline and Rb+ transport in human erythrocytes infected with the malaria parasite Plasmodium falciparum. Biochem J. 278:(Pt 2):1991;521-525.
29. Ebel H., Hollstein M., Gunther T. Role of the choline exchanger in Na(+)-independent Mg(2+) efflux from rat erythrocytes. Biochim Biophys Acta. 1559:(2):2002;135-144.
30. Busch A.E., Quester S., Ulzheimer J.C., Waldegger S., Gorboulev V., Arndt P., Lang F., Koepsell H. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem. 271:(51):1996;32599-32604.
31. Busch A.E., Karbach U., Miska D., Gorboulev V., Akhoundova A., Volk C., Arndt P., Ulzheimer J.C., Sonders M.S., Baumann C., Waldegger S., Lang F., Koepsell H. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol. 54:(2):1998;342-352.
32. Nagel G., Volk C., Friedrich T., Ulzheimer J.C., Bamberg E., Koepsell H. A reevaluation of substrate specificity of the rat cation transporter rOCT1. J Biol Chem. 272:(51):1997;31953-31956.
33. Croft S.L., Snowdon D., Yardley V. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J Antimicrob Chemother. 38:(6):1996;1041-1047.
34. Escobar P., Matu S., Marques C., Croft S.L. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B. Acta Trop. 81:(2):2002;151-157.
35. Soto J., Toledo J., Gutierrez P., Nicholls R.S., Padilla J., Engel J., Fischer C., Voss A., Berman J. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis. 33:(7):2001;E57-E61.
36. Le Fichoux Y., Rousseau D., Ferrua B., Ruette S., Lelievre A., Grousson D., Kubar J. Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice. Antimicrob Agents Chemother. 42:(3):1998;654-658.
37. Kuhlencord A., Maniera T., Eibl H., Unger C. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrob Agents Chemother. 36:(8):1992;1630-1634.
38. Schmidt-Ott R., Klenner T., Overath P., Aebischer T. Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 93:(1):1999;85-90.
39. Jha T.K., Sundar S., Thakur C.P., Bachmann P., Karbwang J., Fischer C., Voss A., Berman J. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med. 341:(24):1999;1795-1800.
40. Ancelin M.L., Vial H.J. Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transport. Antimicrob Agents Chemother. 29:(5):1986;814-820.
41. Ancelin M.L., Vial H.J., Philippot J.R. Inhibitors of choline transport into Plasmodium-infected erythrocytes are effective antiplasmodial compounds in vitro. Biochem Pharmacol. 34:(22):1985;4068-4071.
42. Ancelin M.L., Calas M., Bompart J., Cordina G., Martin D., Ben Bari M., Jei T., Druilhe P., Vial H.J. Antimalarial activity of 77 phospholipid polar head analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth. Blood. 91:(4):1998;1426-1437.
43. Kuhar M.J., Murrin L.C. Sodium-dependent, high affinity choline uptake. J Neurochem. 30:(1):1978;15-21.
44. Haga T. Synthesis and release of ( 14 C)acetylcholine in synaptosomes. J Neurochem. 18:(6):1971;781-798.
45. Haga T., Noda H. Choline uptake systems of rat brain synaptosomes. Biochim Biophys Acta. 291:(2):1973;564-575.
46. Yamamura H.I., Snyder S.H. Choline: high-affinity uptake by rat brain synaptosomes. Science. 178:(61):1972;626-628.
47. Koepsell H., Calas M., Bompart J., Cordina G., Martin D., Ben Bari M., Jei T., Druilhe P., Vial H.J. Polyspecific cation transporters in the proximal tubule. Nephrol Dial Transplant. 15:(Suppl 6):2000;3-4.
48. Zhang L., Brett C.M., Giacomini K.M. Role of organic cation transporters in drug absorption and elimination. Annu Rev Pharmacol Toxicol. 38:1998;431-460.
49. Landfear S.M. Genetics and biochemistry of Leishmania membrane transporters. Curr Opin Microbiol. 3:(4):2000;417-421.
50. Kandpal M., Tekwani B.L. Polyamine transport systems of Leishmania donovani promastigotes. Life Sci. 60:(20):1997;1793-1801.
51. Richard D., Kundig C., Ouellette M. A new type of high affinity folic acid transporter in the protozoan parasite Leishmania and deletion of its gene in methotrexate-resistant cells. J Biol Chem. 277:(33):2002;29460-29467.
52. Ouellette M., Drummelsmith J., El-Fadili A., Kundig C., Richard D., Roy G. Pterin transport and metabolism in Leishmania and related trypanosomatid parasites. Int J Parasitol. 32:(4):2002;385-398.
53. Lux H., Hart D.T., Parker P.J., Klenner T. Ether lipid metabolism, GPI anchor biosynthesis, and signal transduction are putative targets for anti-leishmanial alkyl phospholipid analogues. Adv Exp Med Biol. 416:1996;201-211.
54. Lux H., Heise N., Klenner T., Hart D., Opperdoes F.R. Ether - lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether - lipid analogues in Leishmania. Mol Biochem Parasitol. 111:(1):2000;1-14.
55. Perez-Victoria J.M., Perez-Victoria F.J., Parodi-Talice A., Jimenez I.A., Ravelo A.G., Castanys S., Gamarro F. Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator. Antimicrob Agents Chemother. 45:(9):2001;2468-2474.
56. Rybczynska M., Liu R., Lu P., Sharom F.J., Steinfels E., Pietro A.D., Spitaler M., Grunicke H., Hofmann J. MDR1 causes resistance to the antitumour drug miltefosine. Br J Cancer. 84:(10):2001;1405-1411.
57. Tuller G., Nemec T., Hrastnik C., Daum G. Lipid composition of subcellular membranes of an FY1679-derived haploid yeast wild-type strain grown on different carbon sources. Yeast. 15:(14):1999;1555-1564.